e-learning
resources
Munich 2006
Wednesday 06.09.2006
Interstial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of BALF in differential diagnosis of smoking related interstitial lung diseases
J. J. Domagala-Kulawik, R. Chazan (Warsaw, Poland)
Source:
Annual Congress 2006 - Interstial lung diseases
Session:
Interstial lung diseases
Session type:
Poster Discussion
Number:
4771
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. J. Domagala-Kulawik, R. Chazan (Warsaw, Poland). Role of BALF in differential diagnosis of smoking related interstitial lung diseases. Eur Respir J 2006; 28: Suppl. 50, 4771
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases
Source: Eur Respir Mon; 2009: 46: 36–46
Year: 2009
Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Correlation between imaging fibrosis severity and bronchoalveolar lavage pattern in interstitial lung disease
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Smoking and interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 428-435
Year: 2015
Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Analysis of functional, radiologic, and bronchoalveolar lavage findings in patients with diffuse parenchymal lung diseases
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Source: Eur Respir J 2003; 22: 239-244
Year: 2003
Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Source: Eur Respir J 2004; 24: 964-970
Year: 2004
An integrated approach in the diagnosis of smoking-related interstitial lung diseases
Source: Eur Respir Rev 2012 21:207-217
Year: 2012
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP)
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Peroxidation processes, cytokines, BALF and blood cytology in patients with occupational lung diseases and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 275s
Year: 2002
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Source: Eur Respir J 2009; 33: 882-896
Year: 2009
Comparative characteristics of cytokines in BAL fluid in occupational lung diseases and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006
Ability of the lung clearance index to monitor progression of early lung disease in children with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept